August 2022
Chronic Lymphocytic Leukemia (CLL)
Clinical trials play a vital role in moving treatment and research advances forward. The Clinical Trials 201 program tackles common misconceptions and provides clear, actionable information about trials, sharing tools and resources for patients with CLL. Clinical Trials 201 includes:
Understanding Clinical Trial Terminology
The Benefits of CLL Clinical Trials
Accessing Clinical Trials
Clinical Trial Safety
Resource Guides (printer-friendly)
Related Resources
This program is supported by Pharmacyclics, an AbbVie Company, and through generous donations from people like you.